Discovery of a Bromodomain and Extra Terminal Domain (BET) Inhibitor with the Selectivity for the Second Bromodomain (BD2) and the Capacity for the Treatment of Inflammatory Diseases-Reference-Cited by-全球学者库

Discovery of a Bromodomain and Extra Terminal Domain (BET) Inhibitor with the Selectivity for the Second Bromodomain (BD2) and the Capacity for the Treatment of Inflammatory Diseases

Published:2023-07-21 Issue:15 Volume:66 Page:10824-10848
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Wang Zhijie¹,Yin Li²,Xiong Zhenghan²,Huang Fei¹,Yang Na¹,Jiang Fei¹,Li Huili¹,Cui Yong¹,Ren Jiwei¹,Cheng Zitian¹,Jia Kun¹,Lu Tao¹³,Zhu Jiapeng⁴^ORCID,Hu Qinghua²^ORCID,Chen Yadong¹^ORCID

Affiliation:

1. School of Science, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, P. R. China

2. School of Pharmacy, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, P. R. China

3. State Key Laboratory of Natural Medicines, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, P. R. China

4. School of Medicine and Life Sciences, State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, P. R. China

Funder

China Pharmaceutical University

Natural Science Foundation of Jiangsu Province

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c01028

Reference59 articles.

1. Biological and clinical significance of T helper 17 cell plasticity

2. Cytokine‐regulated Th17 plasticity in human health and diseases

3. The role of Th17 cells in psoriasis

4. A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders

5. The involvement of TH17 cells in the pathogenesis of IBD

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a brain-permeable bromodomain and extra terminal domain (BET) inhibitor with selectivity for BD1 for the treatment of multiple sclerosis;European Journal of Medicinal Chemistry;2024-02